OTULIN is a deubiquitinase that specifically cleaves linear ubiquitin chains. Here we demonstrate that the ablation of Otulin selectively in keratinocytes causes inflammatory skin lesions that develop into verrucous carcinomas. Genetic deletion of Tnfr1, knockin expression of kinase-inactive Ripk1 or keratinocyte-specific deletion of Fadd and Mlkl completely rescues mice with OTULIN deficiency from dermatitis and tumorigenesis, thereby identifying keratinocyte cell death as the driving force for inflammation. Single-cell RNA-sequencing comparing non-lesional and lesional skin reveals changes in epidermal stem cell identity in OTULIN-deficient keratinocytes prior to substantial immune cell infiltration. Keratinocytes lacking OTULIN display a type-1 interferon and IL-1β response signature, and genetic or pharmacologic inhibition of these cytokines partially inhibits skin inflammation. Finally, expression of a hypomorphic mutant Otulin allele, previously shown to cause OTULIN-related autoinflammatory syndrome in humans, induces a similar inflammatory phenotype, thus supporting the importance of OTULIN for restraining skin inflammation and maintaining immune homeostasis.
The skin protects our body from external insults and against dehydration. Keratinocytes, the epithelial cells of the skin, undergo a tightly regulated differentiation program that enables the formation of a fully functional epidermal permeability barrier. Keratinocyte stem cells replace cells that have been lost through normal differentiation or programmed cell death. In recent years, a wide variety of keratinocyte stem cells have been identified that reside in different skin compartments. However, in pathophysiological conditions, such as in inflammation, wounding, or tumorigenesis, stem cells can display a tremendous plasticity and perform functions that are not part of their homeostatic repertoire1,2,3. The molecular mechanisms underlying stem cell plasticity in different pathophysiological skin states are largely unknown.
Linear ubiquitination represents a post-translational modification that is characterized by the addition of methionine (M1)-linked ubiquitin chains on protein substrates by the linear ubiquitin chain assembly complex (LUBAC)4. LUBAC, which consists of the proteins SHARPIN, HOIP, and HOIL-1, is the only currently known E3 ligase complex responsible for M1 ubiquitin chain formation5,6,7, and mice deficient for SHARPIN or lacking HOIL-1 or HOIP in keratinocytes develop severe dermatitis8,9,10. Indeed, LUBAC-mediated linear ubiquitination controls the activation of the pro-inflammatory NF-κB pathway, but also prevents tumor necrosis factor receptor 1 (TNFR1)-mediated cell death4,11. OTULIN (OTU deubiquitinase with linear linkage specificity, also known as Fam105b or Gumby) is the sole deubiquitinase that exhibits a unique affinity for linear ubiquitin chains12,13,14. Patients harboring loss-of-function mutations in OTULIN develop a severe auto-inflammatory disease with skin involvement, termed ORAS (OTULIN-related auto-inflammatory syndrome, also known as otulipenia)15,16. Mice deficient for OTULIN or expressing a catalytically inactive OTULIN mutant die midgestation as a result of aberrant cell death mediated by TNFR1-signaling and receptor-interacting protein kinase 1 (RIPK1) kinase activity13,17. OTULIN directly binds to HOIP, and downregulation of OTULIN results in enhanced M1-linked ubiquitination of LUBAC and its substrates. These findings indicate that OTULIN promotes LUBAC activity by inhibiting LUBAC autoubiquitination and degradation17,18,19,20.
Recent data point to the fact that cell death and inflammation are intricately linked, and cell death mechanisms have been shown to initiate inflammatory responses21. The balance between pro-inflammatory gene activation and cell death relies on signal transduction by death receptors, such as TNFR121,22. The binding of TNF to TNFR1 induces the formation of the TNFR1 signaling complex, also termed complex I. Various adaptor proteins are sequentially recruited into this complex, resulting in the activation of pro-inflammatory NF-κB and MAPK signaling. Ubiquitination of distinct proteins in this complex is paramount for its assembly and downstream signaling. However, TNF can also induce inflammation by promoting cell death. In these circumstances, a different molecular complex is assembled, resulting in the formation of an apoptosis-inducing complex IIa, consisting of FADD (Fas-associated death domain) and caspase-8, or complex IIb, which relies on FADD and RIPK1 enzymatic activity, or in the formation of a necroptosis-inducing complex (termed necrosome) that depends on RIPK1 and RIPK3 kinase-activity and subsequent phosphorylation of MLKL (mixed lineage kinase domain-like)21,22. Genetic studies in mice have revealed that defects in proper cell death regulation may induce severe inflammatory skin phenotypes caused by keratinocyte apoptosis and necroptosis, demonstrating that keratinocyte death is a potent trigger of skin inflammation and pathology23.
Here, we set out to investigate the importance of OTULIN-mediated linear deubiquitination for skin homeostasis by selectively deleting OTULIN in keratinocytes (ΔKerOTULIN) in mice. ΔKerOTULIN mice develop delineated inflammatory skin lesions from young age on that progress into verrucous carcinomas. Through genetic and pharmacological intervention studies, and by performing single-cell analysis on lesional and non-lesional skin of ΔKerOTULIN mice, we identify the signaling pathways through which these lesions appear, allowing us to get new insights on the molecular events that regulate skin homeostasis and mediate skin inflammation.
ΔKerOTULIN mice exhibit inflammatory skin lesions that develop into verrucous carcinomas
To investigate the role of OTULIN in the epidermis, Otulinfl/fl mice24 were crossed to the Keratin-14 Cre line to enable Cre-mediated recombination and OTULIN deletion selectively in keratinocytes25. Immunoblot analysis of primary keratinocyte cultures isolated from keratinocyte-specific OTULIN-deficient (ΔKerOTULIN) mice revealed efficient deletion of OTULIN (Supplementary Fig. 1a). ΔKerOTULIN mice were born with normal Mendelian segregation, but developed delineated inflamed skin lesions on back and tail skin (Fig. 1a). These skin lesions in ΔKerOTULIN mice could already be observed from postnatal day (P) 6 onwards (Supplementary Fig. 1b). Skin pathology was confirmed by histology on lesional back skin from adult 7-week old ΔKerOTULIN mice revealing marked epidermal hyperplasia and melanophagy (Fig. 1b). These inflammatory skin lesions progressively developed into verrucous carcinoma (Fig. 1b), defined as a well-differentiated variant of squamous cell carcinoma with minimal metastatic potential26, and mice had to be sacrificed prior to tumor formation due to ethical concerns. Skin inflammation in ΔKerOTULIN mice was also evident based on the enhanced epidermal thickness of lesional skin of these mice, while the epidermis of non-lesional skin was not thickened and was comparable to the skin of control (OTULINfl/fl) littermate mice (Fig. 1c). ΔKerOTULIN mice also showed a loss in permeability barrier integrity in lesional skin, as assessed by transepidermal water loss (TEWL) measurements (Fig. 1d). Dermatitis in ΔKerOTULIN skin was further confirmed by the marked presence of CD11b- and F4/80-positive macrophages in ΔKerOTULIN skin lesions (Fig. 1e), and aberrant keratinocyte differentiation could be demonstrated in both lesional and non-lesional skin of ΔKerOTULIN mice based on abnormal Keratin-6 (K6) and filaggrin staining of skin sections (Fig. 1e). ΔKerOTULIN skin also exhibited substantial hypersebacea relative to the skin of control mice, as assessed by Oil Red O staining (Supplementary Fig. 1c).
Quantitative PCR analysis on epidermal tail lysates showed an increase in the expression levels of interleukin (IL)-4 and -13, which are both linked to epidermal barrier function27, the pro-inflammatory cytokines TNF and IL-6, the chemokine MCP-1 (Monocyte Chemoattractant Protein-1, also known as CCL2), and the antimicrobial peptide S100A8 (Fig. 1f) in ΔKerOTULIN skin compared to control skin, confirming the loss of barrier integrity and the inflammatory condition of ΔKerOTULIN skin. ΔKerOTULIN mice also exhibited enhanced circulating levels of IL-6, TNF, MCP-1, and IL-17 relative to control mice (Fig. 1g), indicating systemic inflammation, which was also apparent by the bigger size of the skin-draining lymph nodes in ΔKerOTULIN mice compared to control mice (Supplementary Fig. 1d). In agreement with the inflammatory condition of ΔKerOTULIN skin, immunoblotting on epidermal tail lysates revealed an enhanced NF-κB response, as evidenced by the reduced level of IκBα and increased level of phospho-IκBα in ΔKerOTULIN epidermis relative to control epidermis (Fig. 1h). Also, the levels of M1-linked ubiquitin chains were markedly increased in epidermal lysates from ΔKerOTULIN mice (Fig. 1h), in agreement with the function of OTULIN as an M1 ubiquitin-specific deubiquitinase. Together, these data demonstrate the development of a strong but delineated dermatitis in mice that lack OTULIN in keratinocytes, suggesting that proper regulation of LUBAC-mediated linear ubiquitination is needed in order to maintain skin homeostasis.
Ablation of OTULIN in keratinocytes results in enhanced epidermal stem cell proliferation and cell death
LUBAC-mediated linear ubiquitination proved to be important for the prevention of inflammation-induced cell death in the skin8. OTULIN has also been recognized for its role in limiting inflammatory cell death17,24,28,29. Therefore, we quantified the amount of cleaved caspase-3-positive apoptotic cells in ΔKerOTULIN and control skin. A significant accumulation in the number of apoptotic cells could be demonstrated in non-lesional ΔKerOTULIN skin compared to control skin, which was even more pronounced in inflammatory ΔKerOTULIN skin lesions (Fig. 2a, b; Supplementary Fig. 2a). Caspase-3 cleavage was confirmed by immunoblotting on epidermal tail lysates from ΔKerOTULIN mice (Fig. 2c). Enhanced cell death rates in tissues are often accompanied by compensatory cell proliferation. Analysis of ΔKerOTULIN skin sections also showed a marked increase in keratinocyte proliferation in both lesional and non-lesional skin regions, as evidenced by Ki67 staining (Fig. 2a, b; Supplementary Fig. 2b). In agreement, we assessed keratinocyte proliferation dynamics by pulsing ΔKerOTULIN and control skin with the nucleotide analog EdU (5-ethynyl-2′-deoxyuridine) for 3 h prior to analysis. Wholemount immunofluorescence of hair follicles revealed no visible EdU uptake in control skin, while ΔKerOTULIN skin showed extensive EdU uptake, indicating a strong increase in epidermal stem cell proliferation (Fig. 2d). Imaging of tail wholemounts also revealed clear abnormalities in hair follicle structures in ΔKerOTULIN skin, with aberrantly shaped sebaceous glands and marked thickening of the infundibulum (Fig. 2d). Immunofluorescent staining for cleaved caspase-3 on tail wholemount sections confirmed the accumulation of caspase-3-positive dying cells over the entire length of ΔKerOTULIN hair follicles, indicating that in absence of OTULIN, cell viability of hair follicle stem cell (HFSC) populations may be affected (Fig. 2e). To assess whether aberrant cell death precedes the formation of skin lesions in ΔKerOTULIN mice, we next quantified the number of apoptotic cells in mice at a time-point when lesions were not yet apparent, namely at postnatal day P0.5. While epidermal thickness was not significantly altered yet in these newborn ΔKerOTULIN mice, a marked increase in the number of cleaved caspase-3-positive apoptotic interfollicular epidermis (IFE) cells could already be observed in the skin of these mice compared to control mice (Fig. 2f−h).
Keratinocyte hyperproliferation in ΔKerOTULIN mice is indicative for an increase in stem cell proliferative capacity, which is crucial for regenerative responses in the skin1. Indeed, full-thickness skin wounding in ΔKerOTULIN and control mice revealed a marked accelerated wound closure response in the initial phases of wound repair (day 2 and day 4 post-wounding) in ΔKerOTULIN mice. However, when wounds enter the remodeling stage of repair (day 8 post-wounding), wound closure slowed down significantly in ΔKerOTULIN skin compared to control skin (Supplementary Fig. 2c−e). Intriguingly, ΔKerOTULIN skin developed cysts and tumor-like lesions at sites of wounding when re-epithelialization was complete (Supplementary Fig. 2e), confirming the enhanced sensitivity of these mice to skin tumorigenesis.
TNFR1-mediated cell death drives inflammation in ΔKerOTULIN mice
The cutaneous inflammation in Sharpincpdm/cpdm mice does not develop in the absence of TNFR15,30,31. However, the lethal dermatitis present in keratinocyte-specific HOIL-1 or HOIP deficient mice is only partially mediated by TNFR18. Therefore, we tested whether genetic ablation of TNFR1 also results in an amelioration of the inflammatory phenotype observed in ΔKerOTULIN skin. Crossing ΔKerOTULIN mice onto a TNFR1-deficient background completely prevented dermatitis (Fig. 3a), even at old age (Supplementary Fig. 3a), and ΔKerOTULIN-TNFR1−/− mice showed significantly reduced IL6, TNF, and IL17 levels in their serum (Fig. 3b). Moreover, deletion of one functional TNFR1 allele partially protected ΔKerOTULIN skin against the formation of skin lesions and inflammatory cytokine production (Fig. 3b). In agreement, the epidermis of ΔKerOTULIN-TNFR1−/− skin was not thickened and was comparable to the skin of control (OTULINfl/fl) littermate mice (Fig. 3c).
Since RIPK1 kinase activity regulates cell death in the TNFR1-complex II, we next evaluated the contribution of RIPK1 kinase-dependent cell death to the inflammatory skin phenotype of ΔKerOTULIN mice. For this, we crossed ΔKerOTULIN mice onto a RIPK1 kinase-inactive genetic (Ripk1D138N/D138N) background. ΔKerOTULIN-RIPK1D138N/D138N mice were also completely protected from dermatitis development (Fig. 3a), even at old age (40 weeks and older) (Supplementary Fig. 3b), and showed normal serum levels of inflammatory cytokines and chemokines (Fig. 3b), and normal thickness of the epidermis (Fig. 3c). RIPK1 kinase activity can induce both FADD-dependent apoptosis and RIPK3/MLKL-dependent necroptosis32. Hence, we next crossed ΔKerOTULIN mice with mice that have a floxed Fadd and Mlkl allele, generating mice that lack OTULIN, FADD, and MLKL specifically in keratinocytes. These ΔKerOTULIN/FADD/MLKL mice were completely lesion-free (Fig. 3a and Supplementary Fig. 3c), exhibited normal circulating cytokine levels (Fig. 3b), and normal thickness of the epidermis (Fig. 3c), proving that cell death is the driving force of inflammation in ΔKerOTULIN mice. ΔKerOTULIN mice only deficient for MLKL in keratinocytes were partially protected from dermatitis. The tail phenotype was completely rescued in ΔKerOTULIN/MLKL mice, however some mice still developed lesions on the back skin (Supplementary Fig. 3d). Finally, we observed complete protection from dermatitis when ΔKerOTULIN mice were crossed onto a MyD88-deficient genetic background, suggesting that microbial components could be involved in driving dermatitis in OTULIN-deficient skin (Fig. 3a).
Primary mouse keratinocytes (PMKs) isolated from Sharpincpdm/cpdm mice are highly sensitive to cell death induced by TNF stimulation6,33, and HOIP-deficient cells are less viable even in the absence of exogenous stimuli8. OTULIN-deficient PMKs, however, are equally resistant to TNF-induced cell death as control PMKs (Fig. 3d). However, when PMKs were primed with type II IFN (IFNγ) and subsequently stimulated with TNF, a significant larger amount of OTULIN-deficient keratinocytes were shown to die compared to control PMKs, as measured by uptake of a cell impermeable dye over a 24 h time course (Fig. 3d, e). In contrast, no significant differences in NF-κB and p38 MAPK signaling or production of cytokines or chemokines could be observed between control and ΔKerOTULIN PMKs after stimulation with TNF (Fig. 3f and Supplementary Fig. 3e). It should be noted that the residual OTULIN band observed in ΔKerOTULIN PMKs might originate from feeder cells that can still be present in PMK cultures. A pronounced reduction could be observed in the expression of SHARPIN, HOIL-1, and HOIP in ΔKerOTULIN PMKs (Fig. 3f), in agreement with previous studies that have shown reduced expression of LUBAC components in OTULIN-deficient cells and tissues15,17,24,28,29, and consistent with the concept that OTULIN maintains LUBAC function by suppressing its auto-ubiquitination and degradation17. Indeed, pretreatment of PMKs with the proteasome inhibitor MG132 could restore SHARPIN and HOIP levels in ΔKerOTULIN cultures (Supplementary Fig. 3f). Finally, analysis of linear ubiquitination by specific pulldown of ubiquitin-binding domain-containing proteins using recombinant GST-UBAN (Ub-binding domain in ABIN proteins and NEMO), demonstrated a strong increase in M1-ubiquitination in primary OTULIN-deficient keratinocyte cultures after stimulation with TNF, compared to cultures from control mice (Fig. 3g), confirming the importance of OTULIN in restricting M1 ubiquitination in keratinocytes. Immunoblotting for RIPK1 in immunoprecipitation lysates of PMKs showed a decreased expression of RIPK1 in ΔKerOTULIN PMKs (Fig. 3g), although this altered RIPK1 expression was not observed in epidermal tails lysates isolated from ΔKerOTULIN mice (Supplementary Fig. 3g).
In conclusion, we could demonstrate that dermatitis and tumor development in ΔKerOTULIN mice depends on the cytotoxic activity of TNF driving FADD- and RIPK1 kinase-dependent death of keratinocytes. The complete rescue from dermatitis upon genetic deletion of both FADD and MLKL proves that keratinocyte cell death is the driving force of the skin inflammation and tumorigenesis in ΔKerOTULIN mice.
OTULIN-deficiency in keratinocytes perturbs stem cell lineage and induces cutaneous infiltration of innate immune cells
To better characterize the inflammatory phenotype of ΔKerOTULIN mice and to gain insights into the cellular differences between lesional and non-lesional ΔKerOTULIN skin, we next performed single-cell RNA-sequencing (scRNAseq) on live cells sorted from control wild-type (WT, OTULINfl/fl; n = 1) skin and lesional (L; n = 3) and non-lesional (NL; n = 2) ΔKerOTULIN skin. Following pre-processing of the data according to the Marioni pipeline, poor quality cells were excluded34. Firstly, unsupervised global clustering into populations was performed with affinity propagation according to the expression of high variance genes (Fig. 4a). The different cell populations that were delineated by unbiased clustering were annotated according to the expression of cell markers adapted from Joost et al.35 (Supplementary Fig. 4a). Next, we determined which cells originated from the three different conditions. This analysis revealed a marked clustering of the control (WT) cells within the different cell populations, which was opposite to the distribution of the lesional cells (L) within the clusters. This was remarkably clear in the keratinocyte and fibroblast clusters (Fig. 4b). Interestingly, ΔKerOTULIN non-lesional (NL) cells were distributed over the entire keratinocyte and fibroblast cluster (Fig. 4b, middle panel). These cell-types are undergoing major changes in overall gene expression in non-lesional ΔKerOTULIN skin, resulting in the presence of cells with expression profiles that are highly similar to WT cells, alongside cells that are highly similar to lesional cells and cells that are clearly transitioning in between these two ends of the expression profile spectrum.
scRNAseq confirmed a strong infiltration of innate immune cells in lesional ΔKerOTULIN skin, while in non-lesional ΔKerOTULIN skin only a slight increase in these immune cells could be observed relative to the situation in WT skin (Fig. 4b, c). Subclustering and annotation of this immune cell population revealed that this cluster harbors mainly macrophages and dendritic cells (Fig. 4c). The gradual infiltration of immune cells in ΔKerOTULIN skin demonstrates the progressive nature of the inflammatory phenotype that develops in these mice. The higher abundance of innate immune cells in lesional ΔKerOTULIN skin was confirmed by flow cytometry, showing a significant increase in the total number of CD45+ immune cells in lesional skin versus non-lesional ΔKerOTULIN or control skin (Fig. 4d). A marked infiltration of F4/80-positive macrophages, cDC1, cDC2, eosinophils, and Langerhans cells was observed in lesional ΔKerOTULIN skin relative to non-lesional ΔKerOTULIN or control skin in both flow cytometry and scRNAseq (Fig. 4d, e; Supplementary Fig. 4b). Interestingly, the most substantial difference that could be observed in lesional ΔKerOTULIN versus non-lesional skin according to flow cytometric analyses was an increase in the number of inflammatory macrophages (CD45+ CD11b+ F4/80+ cells) (Fig. 4d). scRNAseq analysis also revealed extensive changes in the T-cell population, where a substantial infiltration of regulatory T-cells (Tregs) occurred in both lesional and non-lesional ΔKerOTULIN skin (Supplementary Fig. 4c−e), which was confirmed by flow cytometric quantification of the number of FoxP3+ T-cells (Supplementary Fig. 4f).
Our scRNAseq data also showed that several keratinocyte populations marked by HFSC markers, such as Lgr5+, Lrig1+, and Sox9+ HFSCs, show a gradual expansion in both lesional and non-lesional skin, while others, such as CD34+ keratinocytes, gradually decrease in frequency in non-lesional and lesional ΔKerOTULIN skin (Fig. 4f and Supplementary Fig. 4g). These data indicate that stem cells display a high degree of plasticity in the inflammatory skin condition in ΔKerOTULIN skin, suggesting that defects in proper regulation of linear ubiquitination are important for stem cell lineage in the skin. These stem cell changes are already initiated prior to the massive infiltration of immune cells into the skin, as stem cell populations exhibit transcriptional changes in non-lesional ΔKerOTULIN skin that does not harbor significantly more immune cells than control skin (Fig. 4e, f).
Type-1 interferons contribute to dermatitis in ΔKerOTULIN mice
Recent studies identified an important role for type-1 interferons (IFNs) in the process of inflammation4,17,24. Expression analysis of IFN-stimulated genes (ISGs) using our scRNAseq dataset indeed revealed an increased expression of ISGs in OTULIN-deficient keratinocytes. Remarkably, multiple ISGs such as Irf3, Irf9, and USP18 were already upregulated in non-lesional ΔKerOTULIN skin, implicating that IFN signaling is an early event in the generation of dermatitic lesions (Fig. 5a). Q-PCR analysis of ΔKerOTULIN and control epidermal tail lysates confirmed the upregulation of ISGs and type-1 IFNs in keratinocytes in the absence of OTULIN (Fig. 5b).
To further investigate whether type-1 IFNs are crucial in driving the skin inflammation in ΔKerOTULIN mice, these mice were crossed to Ifnar1 (Interferon-α receptor 1)-deficient mice. ΔKerOTULIN-IFNAR1−/− mice showed a rescue of the skin phenotype with lower lesion incidence and skin lesions developing later in life compared to ΔKerOTULIN mice (Fig. 5c, d), even at old age (>40 weeks of age) (Supplementary Fig. 3h). In agreement, serum levels of IL-6, TNF, IL-17, and MCP-1 were reduced to baseline in many ΔKerOTULIN IFNAR1−/− mice (Fig. 5e). However, while some ΔKerOTULIN IFNAR1−/− mice were completely protected from dermatitis, others still developed skin inflammation over time (Fig. 5d−f). Finally, immunostaining for the type-1 interferon IFN-β revealed marked expression of this cytokine in lesional ΔKerOTULIN skin (Fig. 5g). Collectively, these data demonstrate that the production of type-1 IFNs critically contributes to the formation of inflammatory skin lesions in ΔKerOTULIN mice.
Dermatitis in ΔKerOTULIN mice is mediated by Interleukin-1β released by innate immune cells
We next set out to identify the signals driving the response of OTULIN-deficient keratinocytes to inflammation. Therefore, we made use of the NicheNet algorithm designed to infer ligand-receptor links between interacting cells by combining transcriptome data of interacting cells with existing knowledge on gene regulatory networks36. NicheNet analysis was applied to predict the ligands that are produced by innate immune cells and bind to receptors on keratinocytes, causing the changes in keratinocyte gene expression profiles (Fig. 6a). One of the top predicted ligands which we identified by NicheNet to be produced by infiltrating innate immune cells in lesional skin of ΔKerOTULIN mice and modulating gene expression in keratinocytes, was the cytokine IL-1β (Fig. 6a). This cytokine was also identified by NicheNet as a ligand with putative regulatory potential in keratinocytes when comparing non-lesional skin to control skin (Supplementary Fig. 5a), indicating that IL-1β could be an early mediator of the aberrant keratinocyte behavior in ΔKerOTULIN skin. We next assessed the expression profile of IL-1β and the IL-1 family members IL-1α and IL-18 in our scRNAseq dataset and could observe that IL-1β was indeed strongly produced by immune cells infiltrating lesional skin of ΔKerOTULIN mice (Fig. 6b and Supplementary Fig. 5b). This expression profiling also revealed that macrophages represent the predominant IL-1β-producing cell population (Fig. 6b). Interestingly, next to IL-1β and IL-18, also other genes involved in inflammasome activation and IL-1β production, including caspase-1, ASC, and Nlrp3, were upregulated in keratinocytes of lesional skin of ΔKerOTULIN mice relative to keratinocytes from non-lesional ΔKerOTULIN and wild-type mice (Fig. 6c). To assess the functional importance of IL-1β in the pathology of ΔKerOTULIN mice, we next treated ΔKerOTULIN mice with Anakinra, a recombinant version of the human interleukin-1 receptor (IL1R), blocking the binding of IL-1α and IL-1β to the IL1R37. Daily intraperitoneal injections of ΔKerOTULIN mice with Anakinra starting from P18 onwards could suppress dermatitis development in the back skin and tail of these mice, confirming an important contribution of IL-1β in the development of skin lesions (Fig. 6d and Supplementary Fig. 6). The therapeutic potency of Anakinra treatment to ameliorate dermatitis in ΔKerOTULIN mice was also evidenced by a marked restoration of the epidermal permeability function in the lesional skin of these mice (Fig. 6e). These data demonstrate that IL-1β production by infiltrating immune cells contributes to the inflammatory skin phenotype in ΔKerOTULIN mice.
Next to the cytokine IL-1β, we also identified the chemokine MCP-1 by NicheNet as a ligand that could mediate transcriptional changes in keratinocytes when comparing non-lesional skin to control skin (Supplementary Fig. 5a). MCP-1 is a potent chemokine attracting macrophages, therefore we investigated whether blocking MCP-1 could suppress dermatitis in ΔKerOTULIN mice. Indeed, intraperitoneal injections of ΔKerOTULIN mice with a neutralizing α-MCP-1 antibody could ameliorate but not fully suppress the dermatitis in back skin, and completely rescue the inflammatory phenotype in ΔKerOTULIN tail skin (Fig. 6f, g and Supplementary Fig. 6).
Knockin of a human mutation in the murine Otulin gene phenocopies OTULIN-deficiency
Homozygous hypomorphic mutations in the human OTULIN gene, affecting the deubiquitinase activity of the protein, have been shown to underlie the development of a severe life-threatening autoinflammatory syndrome, called ORAS15,16. ORAS patients develop neonatal-onset fever, swollen joints, and diarrhea, but also dermatitis and panniculitis15,16,38. The best characterized homozygous missense mutation L272P (c.815T > C;p Leu272Pro) was shown to result in reduced OTULIN stability and activity towards M1 linked ubiquitin, and patients’ fibroblasts and peripheral blood mononuclear cells showed evidence for increased NF-κB signaling and production of inflammatory cytokines15,16.
To experimentally assess the importance of the L272P mutation, we generated a novel knockin transgenic mouse line expressing the OTULINL272P mutation (amino acid L272 being conserved in mouse) through CRISPR/Cas gene-editing technology. The desired point mutation was verified by PCR amplification and sequencing of the DNA sequence around the target sites (Fig. 7a). Heterozygous OTULINL272P/+ knockin mice were crossed to homozygosity, but no homozygous OTULINL272P/L272P mice were born (Table 1), confirming the lethal phenotype caused by the loss of the deubiquitinase function in these mice, in agreement with what has been shown before in OTULIN knockout mice15,24, in knockin mice that express catalytically inactive (C129A) OTULIN17, and in gumby mice that have a point mutation (W96R or D336E) in Otulin that abolishes its ability to bind to ubiquitin13. However, the OTULINL272P/L272P lethality could be rescued when OTULINL272P mice were crossed into a caspase-8 and RIPK3 deficient background (Table 1 and Fig. 7b, c). OTULINL272P/L272Pcasp8−/−RIPK3−/− mice were born in Mendelian numbers and developed normally without any sign of inflammation (Table 1, Fig. 7b, c) with the exception of the lymphoproliferative syndrome that develops in Casp8−/−RIPK3−/− mice, as previously shown39,40. This rescue implies that aberrant cell death triggers lethality in OTULINL272P/L272P mice.
We next crossed OTULINL272P/+ knockin mice with heterozygous keratinocyte-specific OTULIN deficient mice, generating OTULINL272P/ΔKer mice, having one L272P knockin allele in all cells and tissues, and one OTULIN knockout allele specifically in keratinocytes. These mice develop skin lesions and verrucous carcinomas on their back skin in a similar manner and timeframe as ΔKerOTULIN mice (Fig. 7b, c). Immunoblotting on PMKs isolated from OTULINL272P/ΔKer mice confirmed the reduced stability of OTULIN, SHARPIN, and HOIP (Fig. 7d).
Together, these findings demonstrate that expression of a human-relevant OTULIN mutation in mice induces a similar inflammatory skin phenotype as observed in keratinocyte-specific OTULIN knockout mice, confirming that proper regulation of linear protein ubiquitination is crucial for mammalian skin homeostasis.
Functional deletion of single LUBAC components leads to the development of inflammatory skin phenotypes of varying severity. While the skin of Sharpincpdm/cpdm mice exhibits overall inflammation resembling atopic dermatitis, mice that lack HOIP or HOIL-1 selectively in keratinocytes develop a more severe cutaneous inflammation that results in early postnatal lethality8,10,30,31. Here, we show that mice lacking OTULIN selectively in keratinocytes exhibit a severe skin inflammation that presents on their tail skin and delineated regions of the back skin. These inflammatory lesions develop into verrucous carcinomas, an uncommon variant of squamous cell carcinomas, that are characterized by exophytic epidermal outgrowths and marked melanophagy, a phenotype that was not observed in mice lacking components of the LUBAC complex. Also, the degree of cutaneous inflammation observed in ΔKerOTULIN mice was markedly milder than the severe skin phenotype observed in mice lacking HOIP or HOIL-1 in keratinocytes, which leads to early postnatal lethality8. Although ΔKerOTULIN skin and keratinocytes showed a significant reduction in expression of LUBAC proteins, still residual LUBAC activity in the skin of these mice can be expected.
ΔKerOTULIN mice are fully protected from dermatitis and skin tumorigenesis when crossed to a TNFR1-deficient or RIPK1 kinase-mutant background. This is in agreement with the phenotype in Sharpincpdm/cpdm mice that also do not develop skin inflammation in the absence of TNFR1 or RIPK1 kinase signaling30,31, but is in contrast to the phenotype of keratinocyte-specific HOIP or HOIL-1 knockout mice that only show a delayed dermatitis in TNFR1 deficient or RIPK1 kinase-dead conditions8. Also, in contrast to primary keratinocytes from Sharpincpdm/cpdm mice that are highly sensitive to TNF-induced cell death, OTULIN-deficient keratinocytes are equally resistant to TNF-induced cell death as control keratinocytes. However, when primary keratinocyte cultures were primed with IFN-γ, ΔKerOTULIN keratinocytes were sensitized to TNF-induced cell death. No differences, however, could be observed in TNF-induced NF-κB and MAPK responses between control and ΔKerOTULIN primary keratinocytes.
The observation that genetic deletion of both FADD and MLKL in keratinocytes protects ΔKerOTULIN mice from dermatitis development, proved that cell death of keratinocytes is the driving force of the cutaneous inflammation developing in ΔKerOTULIN mice. MLKL deficiency could ameliorate but not prevent dermatitis development in ΔKerOTULIN mice, suggesting that both FADD-dependent apoptosis and MLKL-dependent necroptosis are driving the skin lesion development in ΔKerOTULIN mice. Moreover, our data point to keratinocyte cell death preceding inflammation, as we observed apoptotic keratinocytes in ΔKerOTULIN skin sections at a time-point (P0.5) when skin lesions were not apparent yet. Also, the absolute number of infiltrating immune cells was still largely comparable in non-lesional ΔKerOTULIN and control skin in these newborn mice, and no increase in epidermal thickness could be observed, again suggesting that keratinocyte death occurs prior to the inflammation. Our scRNAseq data also pointed out that several subsets of HFSCs expand in a progressive manner in non-lesional and lesional ΔKerOTULIN skin, while other subsets gradually decrease in numbers. Whether these changes in stem cell lineage are due to changes in stem cell death rates or changes in proliferation under influence of OTULIN-deficiency, remains to be elucidated. This withstanding, it is clear that changes in keratinocyte stem cell fates occur prior to the substantial immune infiltration that is present in ΔKerOTULIN skin lesions.
We were able to identify an important role for type 1 IFN signaling in mediating skin inflammation in ΔKerOTULIN mice. Indeed, IFNAR1 deficiency rescued ΔKerOTULIN mice from dermatitis development in about 60% of the mice. These findings agree with previous studies pinpointing a role for type-1 IFNs in OTULIN deficient or mutant mice4,17,24, but implicate that other cytokines are also involved in regulating cutaneous inflammation in ΔKerOTULIN skin. However, it should be noted that the IFNAR1 knockout mice have various immune defects41, and were shown to be resistant to imiquimod-induced skin inflammation42,43. Prediction of ligand-target cell interactions, by combining single-cell expression data with prior knowledge on signaling and gene regulatory networks, allowed us to also identify IL1β as an important cytokine involved in the pathology of ΔKerOTULIN mice. Consequently, pharmacological inhibition of IL1β signaling suppressed dermatitis development in ΔKerOTULIN mice. Inflammatory symptoms in ORAS patients can be managed by neutralization of TNF15,16,29, but IL1β neutralization by Anakinra showed efficacy in a patient with panniculitis and dermatosis16, in agreement with our findings in mice.
OTULIN deficiency has distinct biological effects in different cellular and tissue contexts. OTULIN deletion in macrophages was shown to induce systemic inflammation in mice, while deletion of OTULIN in B- or T-cells did not result in overt phenotypes15. We and others recently showed that selective ablation of OTULIN in hepatocytes (OTULINLPC-KO) results in severe liver disease characterized by fibrotic and neoplastic responses24,28. While FADD deficiency or RIPK1 kinase-dead expression prevented hepatocyte cell death and development of liver disease in OTULINLPC-KO mice, genetic deletion of TNF or TNFR1 did not ameliorate the liver phenotype24, in sharp contrast with our observations in keratinocyte-specific OTULIN-deficient mice, where ablation of TNFR1 signaling resulted in a complete rescue of cutaneous inflammation. These data indicate that OTULIN regulates inflammatory cell death pathways with different modes of action, depending on the cellular context. One possible explanation for this is the difference in Otulin expression levels across different tissues. Indeed, analysis of gene expression in different mouse tissues using the EBI expression atlas shows that Otulin expression strongly differs between different tissues with high expression in skin (Supplementary Fig. 7).
In conclusion, we have shown that linear deubiquitination of proteins by OTULIN serves as a crucial biological mechanism important for the maintenance of skin stem cell homeostasis and the prevention of keratinocyte death and subsequent skin inflammation. This further demonstrates that aberrant cell death can act as the driving force for tissue inflammation and neoplastic responses. In line with our observations, a study by the group of Manolis Pasparakis44, published in this issue of Nature Communications, describes similar findings, confirming the role of OTULIN in preventing skin inflammation by inhibiting the death of keratinocytes.
The following mouse lines were used: OtulinFL24, K14-Cre25, FaddFL45, MlklFL46, Ripk1D138N47, Tnfr1−/−48, Ifnar1−/−49, IL1r−/−50, Myd88−/−51, casp8−/−52, and Ripk3−/−53. All alleles were maintained on a C57BL/6 genetic background. Mice were housed in individually-ventilated cages at the VIB Centre for Inflammation Research, in a specific pathogen-free animal facility at 20−24 °C and 45−65% humidity with a 12 h light/dark cycle and food and water available at libitum. All experiments on mice were conducted according to institutional, national, and European animal regulations for animal testing and research. Animal protocols were approved by the VIB-Ghent University ethical review board.
Generation of OTULINL272P knockin mice
For the generation of OTULINL272P knockin mice, C57BL/6J zygotes were electroporated with 40 ng/µl Cas9 protein (iDT), 8 ng/µl cr/tracrRNA duplex (iDT) with guide sequence 5′ ATGACCCTGAACAGCTCCTG 3′ and 150 ng/µl single-stranded DNA repair template with sequence 5′- AAGTGCCGTTCTTCTCTGTGCTCTTGTTTGCCCGAGACACATCCAATGACCCTGAACAGCCACTGAGGAACCACCTAAACCAGGTGGGACACACGGGGGGCCTTGAGCAGGTGAGTTGTGGC-3′ (iDT) containing the L272P mutation (CTC > CCA). The embryos were transferred to foster mothers the same day through oviduct transfer. Effective mutagenesis was confirmed by sequencing of the Otulin gene on genomic DNA.
Therapeutic treatment studies
ΔKerOTULIN mice were either or not treated with 300 mg/kg Anakinra (Sobi, Kineret 100 mg/0.67 ml) by intraperitoneal (IP) injection daily from the age of 18 days on and for a period of 30 days, or with 40 mg/kg anti-MCP-1 antibody (InVivoMab, BE0185) IP twice a week from the age of 18 days on and for a period of 30 days.
Wound healing assay
Full-thickness wounds on the back skin of shaved mice were made by using an 8 mm punch biopsy needle (Stiefel Instruments) under analgesia and general anesthesia in 7 weeks-old transgenic and control littermates. Wound sizes were measured every other day by two independent researchers, who were blinded to group allocations.
Primary mouse keratinocytes were isolated from ΔKerOTULIN and OTULINfl/fl skin as previously described54. Briefly, shaved back skin was isolated, sterilized, and floated on 0.25% trypsin overnight. The epidermis was separated from dermis and cultured on confluent feeder cultures.
Immunophenotyping of mouse skin was performed on single-cell suspensions obtained following trypsin digestion for 1 h at 37 °C and subsequent digestion with collagenase type-1 (1.25 mg/ml; GIBCO), type-2 (0.5 mg/ml, Sigma) and type-4 (0.5 mg/ml, Sigma) for 30−45 min. Cells were stained with the following fluorochrome-linked antibodies, as listed in Supplementary Table 1. Prior to measuring, counting beads (Life Technologies) were added to the cells. Measurements were performed on a BD Fortessa 5-laser cytometer and analyzed using FlowJo 10.6.1. software (Tree Star).
Dewaxed paraffin or frozen skin sections or horizontal tail wholemounts were labeled with respective antibodies listed in Supplementary Table 1. As secondary antibodies donkey-anti-mouse 488 AlexaFluor (1:2000) and goat-anti-rabbit DyLight 586 (1:2000) were used in combination with Dapi.
Dewaxed paraffin skin sections were subjected to heat-mediated antigen retrieval (citrate buffer; pH = 6) and labeled with Ki-67 Ab (1: 1000; Cell Signaling Technology, D3B5, 12202) or cleaved caspase-3 Ab (1: 1000; Cell Signaling Technology, 9661). Slides were incubated with secondary antibody followed by avidin-biotin complexes and peroxidase activity was detected with diaminobutyric acid (DAB) substrate (Vector Laboratories).
Mice were intraperitoneally injected with EdU (1.25 mg/kg in PBS; Click-IT EdU Alexa 488 Imaging Kit) 3 h prior to sacrifice. Staining was performed according to the manufacturers’ instructions.
Transepidermal water loss (TEWL) measurements
Mice were shaved one day prior to TEWL assessment. TEWL was measured on the back skin of anesthetized mice using a TEWA meter (courage and Khazaka, TM 210).
Western blot analysis
Primary keratinocytes and skin tissue were homogenized using E1A lysis buffer (50 mM HEPES pH7.6; 250 mM NaCl; 5 mM EDTA; 0.5% NP40) and NP-40 (50 mM Tris-HCl, pH 7.6; 1 mM EDTA; 150 mM NaCl; 1% NP-40; 0.5% sodiumdeoxycholate; 0.1% SDS) buffer respectively containing protease inhibitors (Roche) and phosphatase inhibitors (Sigma), denaturated in 1 × Laemmli buffer (50 mM Tris-HCl pH8.2; 2% SDS; 10% glycerol; 0.005% BFB; 5% β-mercapto-ethanol) and boiled for 10 min at 95 °C. 20 µg of liver lysates and 20 µg of cell lysates were separated by SDS-polyacrylamide gel electrophoresis (PAGE), transferred to nitrocellulose and analyzed by immunoblotting. Membranes were probed with antibodies against OTULIN (1:1000, Cell Signaling Technology, 14127), JNK (1:1000, BD Bioscience, 554285), phospho-JNK (1:1000, Millipore, PS1019), IκBα (1:1000, Santa Cruz Biotechnologies, sc371), phospho-IκBα (1:1000, Cell Signaling Technology, 9246), p38 MAPK (1:1000, Cell Signaling Technology, CST9212), phospho-p38 MAPK (1:1000, Cell Signaling Technology, CST9215), HOIL-1 (1:2000, kind gift of Dr. Henning Walczak, UCL London), HOIP (1:1000, kind gift of Dr. Rune Damgaard, MRC Cambridge), SHARPIN (1:1000, Proteintech, 14626-1-AP), Ripk1 (1:2000, Cell Signaling Technology, 3493), linear ubiquitin (1:2500, Millipore, clone LUB9, MABS451), caspase-3 (1:1000; Cell Signaling, 9662) and actin-HRP (1:10000, MP Biomedicals). As secondary antibodies, HRP coupled anti-rabbit-HRP, anti-mouse-HRP, and anti-goat-HRP were used (1:2500, Amersham) and detection was done by chemiluminescence (Western Lightning Plus ECL, Perkin Elmer) using the Amersham Imager 600 (GE Healthcare).
Recombinant GST-UBAN was produced in BL21(DE3) cells. In brief, BL21(DE3) cells were transformed with the plasmid encoding GST-UBAN and protein expression was induced with 0.5 M IPTG. After 4 h, cells were collected and lysed in lysis buffer (20 mM Tris-HCl pH 7.5, 10 mM EDTA, 5 mM EGTA, 150 mM NaCl, 1 mM DTT supplemented with phosphatase and protease inhibitor cocktail tablets (Roche Diagnostics)), sonicated, and cleared by centrifugation. After centrifugation, Triton-X100 (0.5% final concentration) was added to the supernatant, which was then transferred onto prewashed glutathione beads and left rotating for 2 h at 4 °C. After incubation, the beads were centrifuged, washed twice with washing buffer (20 mM Tris-HCl pH 7.5, 10 mM EDTA, 150 mM NaCl, 0.5% Triton-X100) and resuspended in resuspension buffer (20 mM Tris-HCl pH 7.5, 0.1% β-mercaptoethanol, 0.05% sodiumazide), ready to be used. Cell lysates from total skin tissue were prepared as described before, protein concentration was determined and 800 μg protein lysate was incubated overnight with GST-UBAN-containing glutathione beads. The next day, the beads were washed three times in RIPA lysis buffer (150 mM NaCl, 1% NP-40, 0.5% Sodium Deoxycholate, 0.1% SDS, 10 mM Tris-HCl pH 8 supplemented with phosphatase and protease inhibitor cocktail tablets (Roche Diagnostics)). Beads were then resuspended in 60 μL 1× laemmli buffer for direct analysis.
Real-time RT PCR
Total RNA was isolated using TRIzol reagent (Invitrogen) and Aurum Total RNA Isolation Mini Kit (Biorad), according to the manufacturer’s instructions. Synthesis of cDNA was performed using Sensifast cDNA Synthesis Kit (Bioline) according to the manufacturer’s instructions. cDNA was amplified on quantitative PCR in a total volume of 5 µl with SensiFAST SYBR® No-ROX Kit (Bioline) and specific primers on a LightCycler 480 (Roche). The reactions were performed in duplicates. The mouse-specific primers used are summarized in Supplementary Table 2.
Cytokine concentrations in serum were determined by a magnetic bead-based multiplex assay using Luminex technology (BioRad), according to the manufacturer’s instructions. Cytokine concentrations observed in OTULINfl/fl and ΔKerOTULIN mice were re-used in figure panels 1g, 3b, and 5e.
scRNA sequencing and analysis
Single-cell suspensions were obtained from total mouse skin as previously described55. Live cells were sorted on FACS Aria by gating for L/D eFluor780 negative cells into PBS with 0.04% BSA, spun down, and resuspended in PBS with 0.04% BSA at a final concentration of 1000 cells/μl. Cellular suspensions (target recovery of 10,000 cells) were loaded on a GemCode Single-Cell Instrument (10x Genomics, Pleasanton) to generate single-cell Gel Bead-in-Emulsion (GEMs). Single-cell RNA-Seq libraries were prepared using GemCode Single-Cell V2 3’Gel Bead and Library kit (10x Genomics) according to the manufacturer’s instructions. Sequencing libraries were loaded at 2.1 pM loading concentration on a HiSeq4000 with custom sequencing metrics (single-indexed sequencing run, 28/8/0/98 cycles for R1/i7/i5/R2) (Illumina, San Diego, CA). Sequencing was performed at the VIB Nucleomics Core (VIB, Leuven, Belgium). Demultiplexing of the raw data and mapping to the mouse genome mm 10 (1.2.0) was done by the 10X CellRanger software (version 2.1.1; cellranger). Preprocessing of the data was done by the scran and scater R package (version 4.1) according to the workflow proposed by the Marioni and Theis lab34. Outlier cells were identified based on 3 metrics (library size, number of expressed genes, and mitochondrial proportion) and cells were tagged as outliers when they were a certain median absolute deviation (MAD) away from the median value of each metric across all cells. For the library size a lower bound of 4 and upper bound of 3 MADs were used, with exception of samples NL1, L3 (upper bound of 2,5 MADs) and WT (upper bound of 4 MADs). For the number of expressed genes the value was set to 4 MADs for both the upper and lower bound, with exception of samples L1, L2 (upper bound of 3 MADs) and L3 (upper bound of 2 MADs). For the mitochondrial proportion 10 MADs were used in samples L1, L2, and NL1, 15 MADs in L3 and 8 MADs in WT. Low-quality cells (low UMI counts, high percentage of mitochondrial genes) were removed from the analysis. A principal component analysis (PCA) plot was generated as an extra filtering using the runPCA function from the scater R package with the default parameters. Genes expressed in less than 3 cells and cells expressing less than 200 genes were removed. The samples were aggregated using the merge function, counts were normalized and log2 transformed using the NormalizeData function, both from the Seurat R package (v3.1.0) using default parameters. Detecting highly variable genes, finding clusters, and creating UMAP plots was done using the Seurat pipeline. Clustering was performed using the first 34 principal components and a resolution of 0.8.
Results are expressed as means ± SEM. Statistical significance between OTULINfl/fl and ΔKerOTULIN was assessed using a Mann−Whitney testing, One-way ANOVA, or Two-way ANOVA with multiple comparisons. Statistical significance between ΔKerOTULIN and the different genetic crosses was assessed using a one-way ANOVA test, followed by Tukey’s multiple comparison test. The analysis was performed with Prism 9 software. To compare the percentages of sytox green positive cells, we analyzed repeated measurements using the method of residual maximum likelihood (REML), as implemented in Genstat version 21. When representative images are shown, a minimum of 12 mice of the relevant genotype were analyzed. Comparison of HFSC marker positive cells in the permanent epidermis was done by Chi-square testing, comparing L or NL gene frequencies to expected frequencies from WT.
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Arwert, E. N., Hoste, E. & Watt, F. M. Epithelial stem cells, wound healing and cancer. Nat. Rev. Cancer 12, 170–180 (2012).
Ge, Y. & Fuchs, E. Stretching the limits: from homeostasis to stem cell plasticity in wound healing and cancer. Nat. Rev. Genet. 19, 311–325 (2018).
Joost, S. et al. Single-cell transcriptomics of traced epidermal and hair follicle stem cells reveals rapid adaptations during wound healing. Cell Rep. 25, 585–597 (2018).
Peltzer, N. et al. LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis. Nature 557, 112–117 (2018).
Gerlach, B. et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591–596 (2011).
Ikeda, F. et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappaB activity and apoptosis. Nature 471, 637–641 (2011).
Tokunaga, F. et al. SHARPIN is a component of the NF-kappaB-activating linear ubiquitin chain assembly complex. Nature 471, 633–636 (2011).
Taraborrelli, L. et al. LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL, and CD95L. Nat. Commun. 9, 3910 (2018).
HogenEsch, H. et al. A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice. Am. J. Pathol. 143, 972–982 (1993).
Seymour, R. E. et al. Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation, and dermatitis. Genes Immun. 8, 416–421 (2007).
Peltzer, N. et al. HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death. Cell Rep. 9, 153–165 (2014).
Keusekotten, K. et al. OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin. Cell 153, 1312–1326 (2013).
Rivkin, E. et al. The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis. Nature 498, 318–324 (2013).
Verboom, L., Hoste, E. & van Loo, G. OTULIN in NF-kappaB signaling, cell death, and disease. Trends Immunol. 42, P590–603 (2021).
Damgaard, R. B. et al. The deubiquitinase OTULIN is an essential negative regulator of inflammation and autoimmunity. Cell 166, 1215–1230 (2016).
Zhou, Q. et al. Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease. Proc. Natl Acad. Sci. USA 113, 10127–10132 (2016).
Heger, K. et al. OTULIN limits cell death and inflammation by deubiquitinating LUBAC. Nature 559, 120–124 (2018).
Elliott, P. R. et al. Molecular basis and regulation of OTULIN-LUBAC interaction. Mol. Cell 54, 335–348 (2014).
Draber, P. et al. LUBAC-recruited CYLD and A20 regulate gene activation and cell death by exerting opposing effects on linear ubiquitin in signaling complexes. Cell Rep. 13, 2258–2272 (2015).
Schaeffer, V. et al. Binding of OTULIN to the PUB domain of HOIP controls NF-kappaB signaling. Mol. Cell 54, 349–361 (2014).
Peltzer, N. & Walczak, H. Cell death and inflammation—a vital but dangerous liaison. Trends Immunol. 40, 387–402 (2019).
Ting, A. T. & Bertrand, M. J. M. More to Life than NF-kappaB in TNFR1 Signaling. Trends Immunol. 37, 535–545 (2016).
Kumari, S. & Pasparakis, M. Epithelial cell death and inflammation in skin. Curr. Top. Microbiol. Immunol. 403, 77–93 (2017).
Verboom, L. et al. OTULIN prevents liver inflammation and hepatocellular carcinoma by inhibiting FADD- and RIPK1 kinase-mediated hepatocyte apoptosis. Cell Rep. 30, 2237–2247 (2020).
Hafner, M. et al. Keratin 14 Cre transgenic mice authenticate keratin 14 as an oocyte-expressed protein. Genesis 38, 176–181 (2004).
Santoro, A. et al. A troubling diagnosis of verrucous squamous cell carcinoma (“the Bad Kind” of Keratosis) and the need of clinical and pathological correlations: a review of the literature with a case report. J. Skin Cancer 2011, 370605 (2011).
Strid, J., McLean, W. H. I. & Irvine, A. D. Too much, too little or just enough: a goldilocks effect for IL-13 and skin barrier regulation? J. Invest. Dermatol. 136, 561–564 (2016).
Damgaard, R. B. et al. OTULIN protects the liver against cell death, inflammation, fibrosis, and cancer. Cell Death Differ. 27, 1457–1474 (2020).
Damgaard, R. B. et al. OTULIN deficiency in ORAS causes cell type-specific LUBAC degradation, dysregulated TNF signalling and cell death. EMBO Mol. Med. 11, e9324 (2019).
Rickard, J. A. et al. TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice. Elife 3, e03464 (2014).
Kumari, S. et al. Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis. Elife 3, e03422 (2014).
Pasparakis, M. & Vandenabeele, P. Necroptosis and its role in inflammation. Nature 517, 311–320 (2015).
Liang, Y. & Sundberg, J. P. SHARPIN regulates mitochondria-dependent apoptosis in keratinocytes. J. Dermatol. Sci. 63, 148–153 (2011).
Lun, A. T., McCarthy, D. J. & Marioni, J. C. A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor. F1000Res. 5, 2122 (2016).
Joost, S. et al. The molecular anatomy of mouse skin during hair growth and rest. Cell Stem Cell 26, 441–457 (2020).
Browaeys, R., Saelens, W. & Saeys, Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nat. Methods 17, 159–162 (2020).
Dinarello, C. A. & Thompson, R. C. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol. Today 12, 404–410 (1991).
Nabavi, M. et al. Auto-inflammation in a patient with a novel homozygous OTULIN mutation. J. Clin. Immunol. 39, 138–141 (2019).
Kaiser, W. J. et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471, 368–372 (2011).
Oberst, A. et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471, 363–367 (2011).
Gough, D. J. et al. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36, 166–174 (2012).
Gui, J. et al. Therapeutic elimination of the type 1 interferon receptor for treating psoriatic skin inflammation. J. Invest. Dermatol. 136, 1990–2002 (2016).
Grine, L. et al. Dual inhibition of TNFR1 and IFNAR1 in imiquimod-induced psoriasiform skin inflammation in mice. J. Immunol. 194, 5094–5102 (2015).
Schünke, H., Goebel, U., Dikic, I. & Pasparakis, M. OTULIN inhibits RIPK1-mediated keratinocyte necroptosis to prevent skin inflammation in mice. Nat. Commun. https://doi.org/10.1038/s41467-021-25945-1 (2021).
Mc Guire, C. et al. Oligodendrocyte-specific FADD deletion protects mice from autoimmune-mediated demyelination. J. Immunol. 185, 7646–7653 (2010).
Murphy, J. M. et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39, 443–453 (2013).
Polykratis, A. et al. Cutting edge: RIPK1 kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo. J. Immunol. 193, 1539–1543 (2014).
Pfeffer, K. et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73, 457–467 (1993).
Muller, U. et al. Functional role of type I and type II interferons in antiviral defense. Science 264, 1918–1921 (1994).
Labow, M. et al. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J. Immunol. 159, 2452–2461 (1997).
Adachi, O. et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9, 143–150 (1998).
Salmena, L. et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev. 17, 883–895 (2003).
Newton, K., Sun, X. & Dixit, V. M. Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol. Cell Biol. 24, 1464–1469 (2004).
Jensen, K. B., Driskell, R. R. & Watt, F. M. Assaying proliferation and differentiation capacity of stem cells using disaggregated adult mouse epidermis. Nat. Protoc. 5, 898–911 (2010).
Hoste, E. et al. Epithelial HMGB1 delays skin wound healing and drives tumor initiation by priming neutrophils for NET formation. Cell Rep. 29, 2689–2701 (2019).
We thank the EUCOMM Consortium for Otulin-targeted ES cells, Manolis Pasparakis for providing RIPK1D138N mice, Vishva Dixit and Genentech for providing RIPK3−/− mice, and Alexander Warren and James Murphy (The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia) for the use of floxed Mlkl mice. We thank Sofie De Schepper for pathological assessment of ΔKerOTULIN mice, and Laetitia Bellen, Dimitri Huygebaert and Dieter Vanhede for animal care. We acknowledge helpful input from Jonathan Maelfait and the VIB BioImaging Core, the VIB Nucleomics Core, and the VIB Flowcore for technical assistance, and all members of the van Loo lab for suggestions and discussions. E.H. is supported by an FWO postdoctoral fellowship and a CRIG Young-Investigator grant. A.M. is supported by an FWO postdoctoral fellowship, L.v.H and L.V. are supported by an FWO FR fellowship. K.R. holds an Odysseus Grant and ERC Advanced grant. Research in the van Loo lab is financed by research grants from the FWO, Stichting Tegen Kanker, the Charcot Foundation, Kom op Tegen Kanker and the “Concerted Research Actions” (GOA) of the Ghent University.
The authors declare no competing interests.
Peer review information Nature Communications thanks Mads Gyrd-Hansen and Shao-Cong Sun for their contribution to the peer review of this work. Peer reviewer reports are available.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Hoste, E., Lecomte, K., Annusver, K. et al. OTULIN maintains skin homeostasis by controlling keratinocyte death and stem cell identity. Nat Commun 12, 5913 (2021). https://doi.org/10.1038/s41467-021-25944-2
MLKL deficiency in BrafV600EPten−/− melanoma model results in a modest delay of nevi development and reduced lymph node dissemination in male mice
Cell Death & Disease (2022)